Navigation Links
Mpex Pharmaceuticals Names Dr. Jeffery Loutit as Chief Medical Officer
Date:9/17/2007

Loutit Brings Significant Experience in Pulmonary and Infectious Disease

Drug Development

SAN DIEGO, Sept. 17 /PRNewswire/ -- Mpex Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on developing products to overcome issues of antibiotic resistance, today announced the appointment of Dr. Jeffery Loutit as the Company's Chief Medical Officer. Dr. Loutit joins Mpex from InterMune, Inc. where since 2001 he has held positions of increasing responsibility and most recently was Vice President of Clinical Science. At InterMune he led multiple Phase 1-3 clinical trials, including two global Phase 3 trials for pirfenidone in patients with idiopathic pulmonary fibrosis. In addition, he negotiated pivotal trial designs for pirfenidone with US and European regulatory agencies and led the late stage clinical development of the anti-infective compound oritavancin, which was subsequently successfully out-licensed.

Prior to entering industry, Dr. Loutit was Chief of the Infectious Diseases Section, Veterans Administration Health Care System in Palo Alto and Assistant Professor of Medicine, Stanford University Medical School, where he published extensively in the area of infectious disease. He received his medical and microbiology degrees from Otago University in New Zealand and is board certified in the US in both infectious disease and internal medicine.

"We believe Jeff will be a great addition to our senior management," said Daniel Burgess, President & CEO of Mpex Pharmaceuticals. "His distinguished reputation and extensive early and late-stage trial experience will be a perfect complement to our scientific and clinical team as we advance our drug candidates. In particular, his protocol design background in both pulmonary and infectious disease medicine is ideally suited to leading our development efforts for MP-376, an agent being developed for the treatment of chronic respiratory infections in patie
'/>"/>

SOURCE Mpex Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Wisconsin IT association names Gee president, CEO
4. Quintessence Biosciences names new president
5. CDW names VP to handle Berbee merger
6. NimbleGen names CFO with capital-raising past
7. Cisco names Berbee a top partner of 2005
8. Cisco names Inacom most innovative partner
9. UW-Madison medical school names new dean
10. GE Healthcare names new CEO
11. Bruker AXS names new leadership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... (PRWEB) March 03, 2015 HubCast® Inc. ... Chain, today announced the expansion of its Global Print ... print to 850 the world’s largest cities across 75 ... extends to 137 countries providing global enterprises ease, speed, ... procurement process from online order to real-world delivery at ...
(Date:3/3/2015)... 2015  Rosa & Co. LLC, a drug development ... research, today announced it has two posters scheduled to ... Pharmacology and Therapeutics meeting in New Orleans, ... Logo - http://photos.prnewswire.com/prnh/20150302/179058LOGO   Bristol- ... describing a quantitative systems pharmacology approach for immuno-oncology drug ...
(Date:3/3/2015)... New Jersey (PRWEB) March 03, 2015 ... has announced today that it has acquired The ... Terms of the transaction were not announced. , ... services to the energy sector including oil and ... energy, and fossil and nuclear power sectors. The ...
(Date:3/3/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/s3s3t8/personalized ) ... report "Personalized Medicine - Scientific and Commercial ... The aim of personalized medicine or individualized ... the right patient and, in some cases, even ... according to his/her genotype. This report describes the ...
Breaking Biology Technology:HubCast Expands Global Print Supply Chain: Launches New Product Suite 2HubCast Expands Global Print Supply Chain: Launches New Product Suite 3HubCast Expands Global Print Supply Chain: Launches New Product Suite 4Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 2Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 3Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 2Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 3
... June 15 Finesse Solutions, LLC, San Jose, CA, a ... its move from a facility in Santa Clara, CA, to ... new address is 71 Daggett Drive, San Jose, CA, 95134. ... from Irvine, CA to Silicon Valley. , , The ...
... MedPredict Market Research, a global provider of pharmaceutical competitive ... entitled "Thought Leader Insight & Analysis: Alzheimer,s Disease," designed ... companies with a stake in the market for diagnostics ... http://www.medpredict.com/website/home.aspx ). , , MedPredict ...
... , - Improving Research ... today announced a new partnership agreement with NextBio,provider of ... discover, and share knowledge locked within public and proprietary,data ... of NextBio,s unique set of ontology-based semantic tools and ...
Cached Biology Technology:New MedPredict Report Reveals Top Alzheimer's Experts' Insights on Diagnostics and Treatments in Development Pipeline 2Elsevier and NextBio Sign Partnership to Enrich ScienceDirect Content, Accelerating Life Sciences, Health Sciences and Chemistry Research 2Elsevier and NextBio Sign Partnership to Enrich ScienceDirect Content, Accelerating Life Sciences, Health Sciences and Chemistry Research 3Elsevier and NextBio Sign Partnership to Enrich ScienceDirect Content, Accelerating Life Sciences, Health Sciences and Chemistry Research 4
(Date:2/11/2015)... 2015 According to ... Market by Product (Cards and Readers, Biometrics, Controllers, Management ... Industrial, Healthcare, Education) and By Geography - Global Forecast and Analysis ... Access Control Market is expected to reach ... CAGR of 10.6% between 2014 and 2020. ...
(Date:2/5/2015)... PARK, N.C. , Feb. 5, 2015  Marken ... specialist logistics company and has launched a new marketing ... Clinical Logistics Organization (CLO).  The new campaign focuses on ... on patient, protocol and shipments. The first ... , aligns Marken,s priorities with its client,s priorities. ...
(Date:2/5/2015)... -- New Market Research Reports Title Global ... 2020 has Been Added to GrandViewReseach.com Report Database ... reach USD 5.10 billion by 2020, according to a ... help identify the site of tissue damage in case ... in medical imaging applications. They have been extensively used ...
Breaking Biology News(10 mins):Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3
... Mich---University of Michigan researchers have determined that most types ... evidence that the deadliest form of skin cancer does ... model. In addition, the researchers found that melanoma ... genes on and off, making the malignant cells a ...
... WASHINGTON Though the massive glaciers of the greater ... steps now to help the region,s communities prepare for ... their lives, according to a new report. Programs that ... needed to adequately address these impacts, the report states. ...
... Ill. University of Illinois researchers are using a new ... in biology the relationship between cell mass and growth ... and bioengineering professor Rashid Bashir, published its results in the ... Academy of Sciences . "It,s merging micro-scale engineering and ...
Cached Biology News:More evidence that melanoma does not conform to the cancer stem cell model 2More evidence that melanoma does not conform to the cancer stem cell model 3Time to prepare for climate change 2Time to prepare for climate change 3Time to prepare for climate change 4Time to prepare for climate change 5Microsensors offer first look at whether cell mass affects growth rate 2
SPDP-Trinitrophenol (TNP) Bovine Serum Albumin...
Direct ELISA Assay Diluent, 100 mL...
Assay Diluent Trial Pack, 4 x 100 mL...
SpectroQuest single beam 1.8nm UV/Vis spectrophotometer; stand-alone unit...
Biology Products: